Extra‐cardiac diagnoses and postnatal outcomes of fetal tetralogy of fallot

Authors:

Abstract
Objective Past studies of fetal tetralogy of Fallot (ToF) have reported extra-cardiac anomalies (ECAs) in 17-45%, genetic syndromes in as low as 20% and poor postnatal outcomes. This study sought to examine these factors in a contemporary cohort. Methods A retrospective review examining 83 fetuses with ToF diagnosed 2012-2019. Referral indication, ToF subtype, additional cardiac, extra-cardiac and genetic diagnoses, pregnancy outcomes and survival were documented. Results The mean gestational age at diagnosis was 23±4 weeks. Of 94% (78/83) with genetic testing, 30% (23/78, 95%CI 21-40%) had genetic anomalies, including Trisomy 21 (39%, 9/23), 22q11 deletion (35%, 8/23), Trisomy 13 or 18 (17%, 4/23) and 9% (2/23) others. A further 4% (3/78) had VACTERL association. Forty-one percent (34/83, 95%CI 31-52%) had ≥1 major ECA of whom 41% (14/34) also had a genetic anomaly. Outcomes: 22% (18/83) pregnancy termination, 5% (4/83) intrauterine death and 72% (60/83) live birth. Of live births, 3% (2/60) experienced neonatal death, 7% late death (4/60) and 90% (54/60) were alive at last follow-up (mean age 3.5±2.4 years). Conclusion In a cohort of fetuses with ToF and high rates of genetic testing, compared to previous reports, genetic anomalies were more common and there were similar rates of ECAs.

This publication has 20 references indexed in Scilit: